Results 211 to 220 of about 284,370 (314)

Sonographic localisation of lymph nodes suspicious of metastatic breast cancer to surgical axillary levels

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 119-138, March 2025.
Sonographic imaging is used to identify the presence, number and location of malignant lymph nodes. Axillary lymph nodes suspicious of harbouring breast cancer metastasis can be localised to three surgical axillary levels. This paper will unpack the axillary anatomy, muscular sonographic landmarks, surgical axillary lymph node levels and the ...
Michelle Fenech, Tracey Burke, Grace Arnett, Alisha Tanner, Natasha Werder   +4 more
wiley   +1 more source

Real-World Study Assessing Characteristics and Treatment Patterns of Patients With Human Epidermal Growth Factor Receptor 2 Immunohistochemistry 0 and Human Epidermal Growth Factor Receptor 2-Low Stage IV Breast Cancer: A Multicenter Retrospective Study. [PDF]

JCO Precis Oncol
Tan CJ, Willis C, Au T, Schabath MB, Li C, Kelley K, Xu X, Park L, Lam C, Mehta S, Kwong J, Brixner D, Stenehjem D.   +12 more
europepmc   +1 more source

Omission of Sentinel Lymph Node Biopsy in Breast Cancer: A Real‐World Validation of the Patient Populations of the SOUND and INSEMA Trials

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background Treatment guidelines recommending omission of axillary surgery in breast cancer are largely based on the SOUND and INSEMA trials. However, the extent to which their study populations represent real‐world patients remains unclear.
Tia Puiras, Eeva Juhanoja, Anselm Tamminen   +2 more
wiley   +1 more source

Auditing shortcut learning and misclassification in artificial intelligence-based breast cancer genomic subtyping. [PDF]

JAMIA Open
Borges J.
europepmc   +1 more source

The Role of Primary Tumor Resection in De Novo Bone‐Only Metastatic Breast Cancer: A Propensity Score‐Matched Analysis

Journal of Surgical Oncology, EarlyView.
ABSTRACT Objective To evaluate the impact of primary tumor resection (PTR) on overall survival (OS) and cancer‐specific survival (CSS) in women with de novo bone‐only metastatic breast cancer (MBC). Methods Women diagnosed with de novo bone‐only metastatic breast cancer between 2010 and 2017 were identified from the Surveillance, Epidemiology, and End ...
Bin Wang, Shasha Liu, Zhidong Huang, Jinhui Wang, Xirui Zhou, Shuo Li, Jianan Chen, Hong Liu   +7 more
wiley   +1 more source

Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Sharaf B, Seif A, Bani Hani H, Alhasan M, Khader R, Al-Yag'oub M, Ghanem A, Bani Ata J, Ajlouni B, Jawarneh Q, Jaffal A, Tamimi F, Jehad S, Al-Abdallat H, Mahafdah O, Abdel-Razeq H.   +15 more
europepmc   +1 more source

Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Colorectal cancer (CRC) has raised considerable health concerns worldwide, with increasing incidence rates, specifically among younger populations. Despite remarkable progress in diagnosing and treating various diseases, the genetic basis of CRC remains only partially understood.
Behnaz Bagheri, Neda Mohsen‐Pour, Najmeh Salehi, Pardis Ketabi Moghadam, Adel Zeinalpour, Amir Sadeghi, Samira Kalayinia, Nayeralsadat Fatemi   +7 more
wiley   +1 more source

Precision immunotherapy for breast cancer: from biomarkers to clinical practice. [PDF]

Cancer Biol Med
Mei J, Yang K, Zhang X, Huang X, Yin Y.
europepmc   +1 more source

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple‐Positive Breast Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao, Hao Liu, Hai‐Ying Yu, Jian Chen, Ming‐Yu Yang, Ya‐Lan Zhang, Gang Tu, Ling‐Feng Tang   +7 more
wiley   +1 more source

Impact of HER2 immunohistochemistry score on pathological complete response and survival in HER2-positive breast cancer treated with neoadjuvant therapy: differential outcomes by hormone receptor status. [PDF]

Front Oncol
Zhang H, Shen X, Kong N.
europepmc   +1 more source